List of Tables
Table 1. Global Urokinase Solution Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Urokinase Solution Market Value by Clinical Use (US$ Million), 2025 vs 2032
Table 3. Global Urokinase Solution Market Value by Administration Approach (US$ Million), 2025 vs 2032
Table 4. Global Urokinase Solution Market Value by Purity (US$ Million), 2025 vs 2032
Table 5. Global Urokinase Solution Market Value by Application (US$ Million), 2025 vs 2032
Table 6. Global Urokinase Solution Market Competitive Situation by Manufacturers in 2025
Table 7. Global Urokinase Solution Sales (BIU) of Key Manufacturers (2021–2026)
Table 8. Global Urokinase Solution Sales Market Share by Manufacturers (2021–2026)
Table 9. Global Urokinase Solution Revenue (US$ Million) by Manufacturers (2021–2026)
Table 10. Global Urokinase Solution Revenue Share by Manufacturers (2021–2026)
Table 11. Global Market Urokinase Solution Average Price (USD/MIU) of Key Manufacturers (2021–2026)
Table 12. Global Key Players of Urokinase Solution, Industry Ranking, 2023 vs 2024 vs 2025
Table 13. Global Key Manufacturers of Urokinase Solution, Manufacturing Sites and Headquarters
Table 14. Global Key Manufacturers of Urokinase Solution, Product Types and Applications
Table 15. Global Key Manufacturers of Urokinase Solution, Date of Entry into the Industry
Table 16. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Urokinase Solution Companies by Tier (Tier 1, Tier 2, Tier 3), based on Urokinase Solution Revenue, 2025
Table 18. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 19. Global Urokinase Solution Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 20. Global Urokinase Solution Sales by Region (BIU), 2021–2026
Table 21. Global Urokinase Solution Sales Market Share by Region (2021–2026)
Table 22. Global Urokinase Solution Sales by Region (BIU), 2027–2032
Table 23. Global Urokinase Solution Sales Market Share by Region (2027–2032)
Table 24. Global Urokinase Solution Revenue by Region (US$ Million), 2021–2026
Table 25. Global Urokinase Solution Revenue Market Share by Region (2021–2026)
Table 26. Global Urokinase Solution Revenue by Region (US$ Million), 2027–2032
Table 27. Global Urokinase Solution Revenue Market Share by Region (2027–2032)
Table 28. North America Urokinase Solution Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. North America Urokinase Solution Sales by Country (BIU), 2021–2026
Table 30. North America Urokinase Solution Sales by Country (BIU), 2027–2032
Table 31. North America Urokinase Solution Revenue by Country (US$ Million), 2021–2026
Table 32. North America Urokinase Solution Revenue by Country (US$ Million), 2027–2032
Table 33. Europe Urokinase Solution Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 34. Europe Urokinase Solution Sales by Country (BIU), 2021–2026
Table 35. Europe Urokinase Solution Sales by Country (BIU), 2027–2032
Table 36. Europe Urokinase Solution Revenue by Country (US$ Million), 2021–2026
Table 37. Europe Urokinase Solution Revenue by Country (US$ Million), 2027–2032
Table 38. Asia Pacific Urokinase Solution Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 39. Asia Pacific Urokinase Solution Sales by Region (BIU), 2021–2026
Table 40. Asia Pacific Urokinase Solution Sales by Region (BIU), 2027–2032
Table 41. Asia Pacific Urokinase Solution Revenue by Region (US$ Million), 2021–2026
Table 42. Asia Pacific Urokinase Solution Revenue by Region (US$ Million), 2027–2032
Table 43. Latin America Urokinase Solution Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 44. Latin America Urokinase Solution Sales by Country (BIU), 2021–2026
Table 45. Latin America Urokinase Solution Sales by Country (BIU), 2027–2032
Table 46. Latin America Urokinase Solution Revenue by Country (US$ Million), 2021–2026
Table 47. Latin America Urokinase Solution Revenue by Country (US$ Million), 2027–2032
Table 48. Middle East and Africa Urokinase Solution Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Middle East and Africa Urokinase Solution Sales by Country (BIU), 2021–2026
Table 50. Middle East and Africa Urokinase Solution Sales by Country (BIU), 2027–2032
Table 51. Middle East and Africa Urokinase Solution Revenue by Country (US$ Million), 2021–2026
Table 52. Middle East and Africa Urokinase Solution Revenue by Country (US$ Million), 2027–2032
Table 53. Global Urokinase Solution Sales (BIU) by Type (2021–2026)
Table 54. Global Urokinase Solution Sales (BIU) by Type (2027–2032)
Table 55. Global Urokinase Solution Sales Market Share by Type (2021–2026)
Table 56. Global Urokinase Solution Sales Market Share by Type (2027–2032)
Table 57. Global Urokinase Solution Revenue (US$ Million) by Type (2021–2026)
Table 58. Global Urokinase Solution Revenue (US$ Million) by Type (2027–2032)
Table 59. Global Urokinase Solution Revenue Market Share by Type (2021–2026)
Table 60. Global Urokinase Solution Revenue Market Share by Type (2027–2032)
Table 61. Global Urokinase Solution Price (USD/MIU) by Type (2021–2026)
Table 62. Global Urokinase Solution Price (USD/MIU) by Type (2027–2032)
Table 63. Global Urokinase Solution Sales (BIU) by Application (2021–2026)
Table 64. Global Urokinase Solution Sales (BIU) by Application (2027–2032)
Table 65. Global Urokinase Solution Sales Market Share by Application (2021–2026)
Table 66. Global Urokinase Solution Sales Market Share by Application (2027–2032)
Table 67. Global Urokinase Solution Revenue (US$ Million) by Application (2021–2026)
Table 68. Global Urokinase Solution Revenue (US$ Million) by Application (2027–2032)
Table 69. Global Urokinase Solution Revenue Market Share by Application (2021–2026)
Table 70. Global Urokinase Solution Revenue Market Share by Application (2027–2032)
Table 71. Global Urokinase Solution Price (USD/MIU) by Application (2021–2026)
Table 72. Global Urokinase Solution Price (USD/MIU) by Application (2027–2032)
Table 73. Syner-Med Company Information
Table 74. Syner-Med Description and Business Overview
Table 75. Syner-Med Urokinase Solution Sales (BIU), Revenue (US$ Million), Price (USD/MIU), and Gross Margin (2021–2026)
Table 76. Syner-Med Urokinase Solution Product
Table 77. Syner-Med Recent Developments/Updates
Table 78. Wanhua Biochem Company Information
Table 79. Wanhua Biochem Description and Business Overview
Table 80. Wanhua Biochem Urokinase Solution Sales (BIU), Revenue (US$ Million), Price (USD/MIU), and Gross Margin (2021–2026)
Table 81. Wanhua Biochem Urokinase Solution Product
Table 82. Wanhua Biochem Recent Developments/Updates
Table 83. Jiangxi Haoran Bio-Pharma Company Information
Table 84. Jiangxi Haoran Bio-Pharma Description and Business Overview
Table 85. Jiangxi Haoran Bio-Pharma Urokinase Solution Sales (BIU), Revenue (US$ Million), Price (USD/MIU), and Gross Margin (2021–2026)
Table 86. Jiangxi Haoran Bio-Pharma Urokinase Solution Product
Table 87. Jiangxi Haoran Bio-Pharma Recent Developments/Updates
Table 88. Jiangsu Aidea Pharmaceutical Company Information
Table 89. Jiangsu Aidea Pharmaceutical Description and Business Overview
Table 90. Jiangsu Aidea Pharmaceutical Urokinase Solution Sales (BIU), Revenue (US$ Million), Price (USD/MIU), and Gross Margin (2021–2026)
Table 91. Jiangsu Aidea Pharmaceutical Urokinase Solution Product
Table 92. Jiangsu Aidea Pharmaceutical Recent Developments/Updates
Table 93. Techpool Company Information
Table 94. Techpool Description and Business Overview
Table 95. Techpool Urokinase Solution Sales (BIU), Revenue (US$ Million), Price (USD/MIU), and Gross Margin (2021–2026)
Table 96. Techpool Urokinase Solution Product
Table 97. Techpool Recent Developments/Updates
Table 98. Microbic Biosystems Company Information
Table 99. Microbic Biosystems Description and Business Overview
Table 100. Microbic Biosystems Urokinase Solution Sales (BIU), Revenue (US$ Million), Price (USD/MIU), and Gross Margin (2021–2026)
Table 101. Microbic Biosystems Urokinase Solution Product
Table 102. Microbic Biosystems Recent Developments/Updates
Table 103. LIVZON Company Information
Table 104. LIVZON Description and Business Overview
Table 105. LIVZON Urokinase Solution Sales (BIU), Revenue (US$ Million), Price (USD/MIU), and Gross Margin (2021–2026)
Table 106. LIVZON Urokinase Solution Product
Table 107. LIVZON Recent Developments/Updates
Table 108. Wuhan Humanwell Pharma Company Information
Table 109. Wuhan Humanwell Pharma Description and Business Overview
Table 110. Wuhan Humanwell Pharma Urokinase Solution Sales (BIU), Revenue (US$ Million), Price (USD/MIU), and Gross Margin (2021–2026)
Table 111. Wuhan Humanwell Pharma Urokinase Solution Product
Table 112. Wuhan Humanwell Pharma Recent Developments/Updates
Table 113. Tianjin Biochem Pharma Company Information
Table 114. Tianjin Biochem Pharma Description and Business Overview
Table 115. Tianjin Biochem Pharma Urokinase Solution Sales (BIU), Revenue (US$ Million), Price (USD/MIU), and Gross Margin (2021–2026)
Table 116. Tianjin Biochem Pharma Urokinase Solution Product
Table 117. Tianjin Biochem Pharma Recent Developments/Updates
Table 118. Key Raw Materials Lists
Table 119. Raw Materials Key Suppliers Lists
Table 120. Urokinase Solution Distributors List
Table 121. Urokinase Solution Customers List
Table 122. Urokinase Solution Market Trends
Table 123. Urokinase Solution Market Drivers
Table 124. Urokinase Solution Market Challenges
Table 125. Urokinase Solution Market Restraints
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report
List of Figures
Figure 1. Product Picture of Urokinase Solution
Figure 2. Global Urokinase Solution Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Urokinase Solution Market Share by Type: 2025 & 2032
Figure 4. Source of Human Urine Product Picture
Figure 5. Reorganization of Technical Production Product Picture
Figure 6. Global Urokinase Solution Market Value by Clinical Use (US$ Million), 2021–2032
Figure 7. Global Urokinase Solution Market Share by Clinical Use: 2025 vs 2032
Figure 8. Pulmonary Embolism Thrombolysis Product Picture
Figure 9. Deep Vein Thrombosis Product Picture
Figure 10. Peripheral Arterial Occlusion Thrombolysis Product Picture
Figure 11. Catheter / Cannula Occlusion Clearance Product Picture
Figure 12. Others Product Picture
Figure 13. Global Urokinase Solution Market Value by Administration Approach (US$ Million), 2021–2032
Figure 14. Global Urokinase Solution Market Share by Administration Approach: 2025 vs 2032
Figure 15. Systemic Infusion Product Picture
Figure 16. Catheter-directed Thrombolysis (CDT) Product Picture
Figure 17. Intracatheter Dwell / Lock Technique Product Picture
Figure 18. Global Urokinase Solution Market Value by Purity (US$ Million), 2021–2032
Figure 19. Global Urokinase Solution Market Share by Purity: 2025 vs 2032
Figure 20. Standard Clinical Grade Product Picture
Figure 21. High-purity / Low-impurity Grade Product Picture
Figure 22. Low Endotoxin / Low Bioburden Specifications Product Picture
Figure 23. Global Urokinase Solution Market Value by Application (US$ Million), 2021–2032
Figure 24. Global Urokinase Solution Market Share by Application: 2025 & 2032
Figure 25. Hospital
Figure 26. Clinic
Figure 27. Others
Figure 28. Global Urokinase Solution Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 29. Global Urokinase Solution Market Size (US$ Million), 2021–2032
Figure 30. Global Urokinase Solution Sales (BIU), 2021–2032
Figure 31. Global Urokinase Solution Average Price (USD/MIU), 2021–2032
Figure 32. Urokinase Solution Report Years Considered
Figure 33. Urokinase Solution Sales Share by Manufacturers in 2025
Figure 34. Global Urokinase Solution Revenue Share by Manufacturers in 2025
Figure 35. Top 5 and Top 10 Global Urokinase Solution Players: Market Share by Revenue in Urokinase Solution in 2025
Figure 36. Urokinase Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 37. Global Urokinase Solution Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 38. North America Urokinase Solution Sales Market Share by Country (2021–2032)
Figure 39. North America Urokinase Solution Revenue Market Share by Country (2021–2032)
Figure 40. United States Urokinase Solution Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Canada Urokinase Solution Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Europe Urokinase Solution Sales Market Share by Country (2021–2032)
Figure 43. Europe Urokinase Solution Revenue Market Share by Country (2021–2032)
Figure 44. Germany Urokinase Solution Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. France Urokinase Solution Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. U.K. Urokinase Solution Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Italy Urokinase Solution Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Russia Urokinase Solution Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Asia Pacific Urokinase Solution Sales Market Share by Region (2021–2032)
Figure 50. Asia Pacific Urokinase Solution Revenue Market Share by Region (2021–2032)
Figure 51. China Urokinase Solution Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Japan Urokinase Solution Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. South Korea Urokinase Solution Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. India Urokinase Solution Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Australia Urokinase Solution Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. China Taiwan Urokinase Solution Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Southeast Asia Urokinase Solution Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Latin America Urokinase Solution Sales Market Share by Country (2021–2032)
Figure 59. Latin America Urokinase Solution Revenue Market Share by Country (2021–2032)
Figure 60. Mexico Urokinase Solution Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. Brazil Urokinase Solution Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. Argentina Urokinase Solution Revenue Growth Rate (US$ Million), 2021–2032
Figure 63. Colombia Urokinase Solution Revenue Growth Rate (US$ Million), 2021–2032
Figure 64. Middle East and Africa Urokinase Solution Sales Market Share by Country (2021–2032)
Figure 65. Middle East and Africa Urokinase Solution Revenue Market Share by Country (2021–2032)
Figure 66. Turkey Urokinase Solution Revenue Growth Rate (US$ Million), 2021–2032
Figure 67. Saudi Arabia Urokinase Solution Revenue Growth Rate (US$ Million), 2021–2032
Figure 68. UAE Urokinase Solution Revenue Growth Rate (US$ Million), 2021–2032
Figure 69. Global Sales Market Share of Urokinase Solution by Type (2021–2032)
Figure 70. Global Revenue Market Share of Urokinase Solution by Type (2021–2032)
Figure 71. Global Urokinase Solution Price (USD/MIU) by Type (2021–2032)
Figure 72. Global Sales Market Share of Urokinase Solution by Application (2021–2032)
Figure 73. Global Revenue Market Share of Urokinase Solution by Application (2021–2032)
Figure 74. Global Urokinase Solution Price (USD/MIU) by Application (2021–2032)
Figure 75. Urokinase Solution Value Chain
Figure 76. Channels of Distribution (Direct Vs Distribution)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
